Maximus’s shares edged up 0.5% following Q2 results largely in line with expectations, reflecting steady revenue but limited upside amid ongoing segment challenges and cautious near-term outlook.
Maximus reported robust performance in Q3 FY2025, achieving a 24% increase in adjusted diluted earnings per share and 15% growth in adjusted EBITDA amid ongoing shifts in governmental policy.